Core Viewpoint - iRhythm Technologies, Inc. is actively participating in the Bank of America Securities 2025 Health Care Conference, showcasing its commitment to advancing digital health solutions [1][2]. Company Overview - iRhythm Technologies, Inc. is a leading digital health care company focused on creating solutions that detect, predict, and prevent disease through the use of wearable biosensors and cloud-based data analytics [3]. - The company utilizes proprietary algorithms to transform data from millions of heartbeats into clinically actionable information, aiming to enhance patient care and health outcomes [3]. Event Participation - iRhythm's management is scheduled to present at the conference on May 13, 2025, at 3:40 p.m. Pacific Time, with a live and archived webcast available for interested parties [2].

Year-over-year revenue grows 8%, operating profit up 14%, non-GAAP operating profit up 13%Operating cash flow of $579 million Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Resmed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended March 31, 2025. Third Quarter 2025 HighlightsAll comparisons are to the prior year period Revenue increased by 8% to $1.3 billion; up 9% on a cons ...

Core Insights - Resmed has appointed Salli Schwartz as Chief Investor Relations Officer, effective April 21, 2025, to lead its global investor relations function [1] - Schwartz brings over two decades of experience in finance roles within health tech and financial services, previously serving as Head of Investor Relations at Illumina [2] - The appointment is seen as critical for advancing Resmed's 2030 strategy aimed at enhancing shareholder value and improving health outcomes for 500 million people globally [3] Company Overview - Resmed is a leader in health technology focused on sleep, breathing, and home care, with a mission to empower individuals in 140 countries to achieve better health [4] - The company utilizes AI-powered digital health solutions and cloud-connected devices to personalize and enhance home healthcare [4]

Core Viewpoint - iRhythm Technologies, Inc. will release its financial results for Q1 2025 on May 1, 2025, followed by a conference call to discuss the results [1]. Company Overview - iRhythm Technologies is a leading digital health care company focused on creating solutions that detect, predict, and prevent disease [3]. - The company utilizes wearable biosensors and cloud-based data analytics combined with proprietary algorithms to transform data from millions of heartbeats into clinically actionable information [3]. - iRhythm's vision emphasizes improving patient care through better data, insights, and health outcomes [3]. Conference Call Details - The conference call will begin at 1:30 p.m. PT / 4:30 p.m. ET on the same day as the financial results release [1]. - Interested parties can access a live and archived webcast of the conference call on the company's investor website [2].

CHATHAM, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a biopharmaceutical company with a portfolio of marketed products and a pipeline of development candidates, today announced the launch of TONIX ONE™, a fully-integrated digital platform designed to help patients better understand and manage their migraine condition. Through a series of strategic partnerships with UpScript Telemedicine, ProModRx, Blink Health and a leading mobile application specializing in d ...

DarioHealth Corp. (NASDAQ:DRIO) Q4 2024 Earnings Conference Call March 10, 2025 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Steven Nelson - Chief Commercial Officer Conference Call Participants Charles Rhyee - TD Cowen Ashok Kumar - ThinkEquity David Grossman - Stifel Operator Good morning, ladies and gentlemen, and welcome to the DarioHealth Fourth Quarter 2024 Results Conference Call. At this time, all lines are in listen-only mode. Foll ...

RadNet (RDNT) Q4 2024 Earnings Call February 28, 2025 10:30 AM ET Company Participants Mark Stolper - Executive VP & CFOHoward Berger - Chairman, President & CEOJohn Ransom - Managing Director, Director of Healthcare ResearchAndrew Mok - Director Conference Call Participants David Macdonald - AnalystBrian Tanquilut - Equity Research Analyst - Healthcare ServicesLarry Solow - Partner & Managing director - Equity AnalystJim Sidoti - Analyst Operator Good day, and welcome to the RadNet Inc. Fourth Quarter twen ...